Cellnovo Group Aktie [WKN DE: A14WF4 / ISIN: FR0012633360]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Cellnovo Group SA

14.02.18		Real-Life Retrospective Study Demonstrates Efficacy of Cellnovo’s Diabetes Management System (Businesswire)
17.01.18		Cellnovo Announces Its Q4 and Full Year 2017 Sales (Businesswire)
16.01.18		Cellnovo Announces Its 2018 Financial Calendar (Businesswire)
16.01.18		Cellnovo: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
08.01.18		Cellnovo Provides an Update on Manufacturing of Insulin Cartridges (Businesswire)
14.12.17		Cellnovo Announces the Launch of the First Clinical Study in the EU-Funded PEPPER Project That Uses Artificial Intelligence for the Management of Type 1 Diabetes (Businesswire)
13.12.17		Cellnovo Announces the CE Marking of the First Bluetooth® and Android™-Enabled Micro-Pump for Insulin Delivery (Businesswire)
08.12.17		Cellnovo: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
03.11.17		Cellnovo: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
03.11.17		Cellnovo Provides an Update on Its Partnership with Diabeloop for the Development of an Artificial Pancreas Solution (Businesswire)
25.10.17		Cellnovo Reports Q3 Sales and Cash Position at September 30, 2017 (Businesswire)
06.10.17		Cellnovo: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
25.09.17		Cellnovo Announces Its Half Year 2017 Results (Businesswire)
08.09.17		Cellnovo Provides Update on 510(k) Submission (Businesswire)
25.07.17		Cellnovo: 2017 First Half Sales (Businesswire)
10.07.17		New Juncker Plan transaction in France: Cellnovo concludes a loan agreement for up to €20 million from the European Investment Bank (Businesswire)
05.07.17		Cellnovo Group: Availability of the 2016 reference document and updated information on the Company’s financing (Businesswire)
26.06.17		Cellnovo: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
20.04.17		Cellnovo Announces that Diabeloop is Launching a CE Marking Registration Study on Artificial Pancreas with Cellnovo Pump (Businesswire)
18.04.17		Cellnovo Acquires Commercial License for Artificial Pancreas Technology from TypeZero Technologies (Businesswire)
16.11.16		Cellnovo Files for 510(k) Approval with the FDA for Its Mobile, Connected, All-in-One Diabetes Management System (Businesswire)
07.11.16		Cellnovo Announces Its 2017 Financial Calendar (Businesswire)
20.10.16		Cellnovo Reports Strong Sales Growth over the First 9 Months of 2016 (Businesswire)
26.09.16		Cellnovo Strengthens Board by Appointing Rémi Soula as a Non-Executive Director (Businesswire)
16.09.16		Cellnovo Raises circa EUR 5.4M in Capital Increase without Preferential Subscription Rights (Businesswire)
07.09.16		Cellnovo: Notice of Half Year Results (Businesswire)
06.09.16		Cellnovo: First Batch of Cellnovo Insulin Cartridges Produced by Flex (Businesswire)
29.07.16		Cellnovo Introduces Manual Blood Glucose Entry Feature for CGM Users (Businesswire)
20.07.16		Cellnovo: 2016 First Half Sales (Businesswire)
23.06.16		New Study Highlights Superior Accuracy of Cellnovo Diabetes Management System Compared to Other Leading Patch Pumps (Businesswire)
09.06.16		Cellnovo Appoints John Brooks as Chairman of the Board of Directors (Businesswire)
27.04.16		Cellnovo Announces Its Full Year 2015 Results and Q1 2016 Sales (Businesswire)
13.04.16		Cellnovo’s Diabetes Management System Selected for Inclusion in EUR 4 Million Diabetes Self-Management Project (Businesswire)
11.04.16		Cellnovo Appoints Sophie Baratte as Interim Chairman of the Board (Businesswire)
15.03.16		Cellnovo and Roche Sign Commercial Blood Glucose Monitor Agreement (Businesswire)
25.02.16		Cellnovo Reaches First Insulin Cartridge Industrialization Milestone (Businesswire)
22.02.16		Cellnovo Appoints Thierry Moulin as Chief Financial Officer (Businesswire)
11.02.16		Cellnovo to Market its Diabetes Management System in Italy (Businesswire)
05.02.16		Cellnovo Partners with US Company TypeZero on Artificial Pancreas Programme (Businesswire)
20.01.16		Cellnovo: 2015 Full Year Sales (Businesswire)
15.01.16		Cellnovo: Half-Yearly Report on the Liquidity Contract With CM-CIC Securities (Businesswire)
15.01.16		Cellnovo: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company (Businesswire)
10.12.15		Cellnovo Admitted to the SRD Long-Seulement Long-Only Deferred Settlement Service (Businesswire)
09.12.15		Cellnovo’s Diabetes Management System Featured in NHS Alliance Programme ‘Communities of Care’ (Businesswire)
07.12.15		Cellnovo: Appointment of Javaid Masoud as Chief Technology Officer (Businesswire)
16.11.15		Cellnovo presents its unique mobile diabetes management system at Nordic Mobile Health Technology Congress (Businesswire)
22.10.15		Cellnovo Records Strong Sales Growth over the First 9 Months of 2015 (Businesswire)
09.10.15		Cellnovo expands its organisation (Businesswire)
29.09.15		Cellnovo Expands Partnership with Flex as It Begins High-Volume Manufacturing of Its Connected All-in-One Diabetes Management System (Businesswire)
22.09.15		Cellnovo joins the Euronext indexes CAC® Small, CAC® Mid & Small and CAC® All-Tradable and announces its 2015/2016 financial calendar (Businesswire)

1 | Weiter

Newssuche

Meistgelesene Nachrichten

Diese AI-Aktie ist Cathie Woods neuer Favorit

JPMorgan: Bitcoin-Miner setzen auf Unternehmensmodell von MicroStrategy

NEL sichert sich Steuergutschrift in Millionenhöhe - Aktie sackt ab

ATX-Papier voestalpine-Aktie: So viel Verlust hätte ein voestalpine-Investment von vor einem Jahr eingefahren

Aktien von PVA TePla und SMA Solar springen hoch, VERBIO-Aktie stürzt ab: Jefferies-Analyst passt zahlreiche Bewertungen an

D-Wave Quantum-Aktie, IonQ-Aktie und Rigetti-Aktie fallen: Aktienrutsch geht trotz Beruhigungssignalen weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	15.01.2025 23:45
Kaufwert:	EUR
	Hinzufügen Speichern